Current understanding and perioperative management of pediatric pulmonary hypertension

Gregory J Latham1, Delphine Yung2

  • 1Department of Anesthesiology and Pain Medicine, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington.

Paediatric Anaesthesia
|November 11, 2018
PubMed

Insights

Pediatric pulmonary hypertension presents diverse causes and risks. Anesthesiologists must understand its physiology and anesthetic implications for improved patient outcomes.

Area of Science:

  • Pediatric Cardiology
  • Anesthesiology
  • Pulmonology

Background:

  • Pediatric pulmonary hypertension (PPH) encompasses diverse etiologies from neonates to young adults.
  • Pediatric pulmonary arterial hypertension (PAH) is progressive and lethal, while neonatal forms, though often transient, carry significant risks.
  • Pulmonary hypertension secondary to left heart disease is an emerging concern in pediatric populations.

Purpose of the Study:

  • To review the current understanding of pediatric pulmonary hypertension (PPH).
  • To highlight the heightened risks associated with anesthesia and sedation in children with PPH.
  • To emphasize the critical role of anesthesiologists in managing PPH patients perioperatively.

Main Methods:

  • Comprehensive literature review of pediatric pulmonary hypertension.
  • Analysis of pathophysiological mechanisms across different PPH subtypes.
  • Evaluation of anesthetic considerations and risk stratification strategies.

Main Results:

  • PPH is a complex condition with varied causes, impacting patient safety during anesthesia.
  • Anesthetic management requires a thorough understanding of PPH pathophysiology.
  • Perioperative care, from preoperative assessment to postoperative management, is crucial for mitigating risks.

Conclusions:

  • Anesthesiologists require specialized knowledge of PPH to ensure patient safety.
  • Effective perioperative strategies are essential for reducing morbidity and mortality in pediatric patients with pulmonary hypertension.
  • This review provides a foundation for understanding PPH physiology and anesthetic implications.

Related Concept Videos

Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
433
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
645
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
605
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
439
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
467